Global Defibrillators Market Forecast 2019-2029

The global defibrillators market is expected to grow at a CAGR of 5.2% from 2017-2022. The market is expected to grow at a CAGR of 6.1% from 2017 to 2029. In 2018, the Implantable Cardioverter Defibrillators segment held 77% of the global defibrillators market.

SKU: PHA0348 Category: Tags: , , Code: PHA0348Pages: 179
Clear

Description

The global defibrillators market is expected to grow at a CAGR of 5.2% from 2017-2022. The market is expected to grow at a CAGR of 6.1% from 2017 to 2029. In 2018, the Implantable Cardioverter Defibrillators segment held 77% of the global defibrillators market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report, you find 179-page report you will receive 74 tables and 125 figures , all unavailable elsewhere.

The 179-page report provides clear detailed insight into the global defibrillators market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

โ€ข Global Defibrillators Market forecast 2019-2029

โ€ข Global Defibrillators market forecast by product:

โ€ข Implantable Cardioverter Defibrillators (ICDs)
โ€ข Transvenous ICDs (T-ICDs)
– Single-Chamber ICDs
– Dual-Chamber ICDs
– Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)

โ€ข Subcutaneous ICDs (S-ICDs)

โ€ข External Defibrillators
โ€ข Manual External Defibrillators

โ€ข Automated External Defibrillators (AEDs)
– Semi-Automated External Defibrillators
– Fully-Automated External Defibrillators

โ€ข Wearable Cardioverter Defibrillators (WCDs)

โ€ข Global Defibrillators market forecast by end-user:
โ€ข Hospitals and Cardiac Centers
โ€ข Pre-hospital Services
โ€ข Public Access
โ€ข Home Care
โ€ข Other-End User

โ€ข Global Defibrillators National Market forecast 2019-2029, covering:

โ€ข North America
โ€ข US
โ€ข Canada

โ€ข Europe
โ€ข Germany
โ€ข UK
โ€ข France
โ€ข Spain
โ€ข Italy
โ€ข Rest of Europe

โ€ข Asia-Pacific:
โ€ข Japan
โ€ข China
โ€ข India
โ€ข Rest of Asia-Pacific

โ€ข Rest of the World
โ€ข Latin America
โ€ข Middle East
โ€ข Africa

Global Defibrillators Market Forecast 2019-2029

โ€ข Analysis of the key factors driving and restraining the growth of the defibrillators market

โ€ข Assessment of selected leading companies, examining recent performance and outlooks:
โ€ข Abbott Laboratories
โ€ข Biotronik SE & Co. KG
โ€ข Boston Scientific Corporation
โ€ข Cardiac Science Corporation
โ€ข LivaNova PLC
โ€ข Medtronic PLC
โ€ข Nihon Kohden Corporation
โ€ข Phillips Healthcare
โ€ข Physio Control Inc.
โ€ข Zoll Medical Corporation

Visiongain’s study is intended for anyone requiring commercial analyses for the Global Defibrillators Market and leading companies. You find data, trends and predictions.

Buy our report today Global Defibrillators Market Forecast 2019-2029: External Defibrillators, Implantable Cardioverter Defibrillators, Transvenous ICD, Subcutaneous ICD, Single-Chamber ICD, Dual-Chamber ICD, Cardiac Resynchronization Therapy Defibrillators (CRT-D), Manual External Defibrillators, Automated External Defibrillators, Wearable Cardioverter Defibrillators.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

1. Report Overview 1.1 Global Defibrillators Market Overview 1.2 Global Defibrillators Market Segmentation 1.3 Why You Should Read This Report 1.4 How This Report Delivers 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report For? 1.7 Methodology 1.7.1 Primary Research 1.7.2 Secondary Research 1.7.3 Market Evaluation & Forecasting Methodology 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About Visiongain 2. Introduction to the Defibrillators Market 2.1 Defibrillators Market Definition 2.2 Evolution of Defibrillators 2.2.1 Snapshot: Evolution of Defibrillators 2.2.2 History of Defibrillators 2.2.3 Currently Available Defibrillators 2.2.4 Future of Defibrillators 3. Global Defibrillators Market Forecast 2019 - 2029 3.1 Global Defibrillators Market Forecast to 2019 - 2029 3.2 Global Defibrillators Market Forecast by Product 2019 - 2029 3.3 Global Defibrillators Market Dynamics, 2018 4. Global Defibrillators Market by Product: Market Forecast 2019 - 2029 4.1 Implantable Cardioverter Defibrillators (ICDs) Market 4.1.1 Transvenous Implantable Cardioverter Defibrillators (T-ICDs) 4.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICD) 4.2 External Defibrillators Market 4.2.1 Manual External Defibrillators Market 4.2.2 Automated External Defibrillators (AEDs) Market 4.2.3 Wearable Cardioverter Defibrillators (WCDs) 5. Global Defibrillators Market by End-User: Market Forecast 2019 - 2029 5.1 Hospitals and Cardiac Centers Market 5.2 Pre-hospital Market 5.3 Public Access Sector Market 5.4 Home Care Market 5.5 Other End Use Sectors Market 6. Leading National Markets Forecast 2019 - 2029 6.1 North America Defibrillators Market Forecast 2019 - 2029 6.1.1 U.S. Defibrillators Market Forecast 2019 - 2029 6.1.2 Canada Defibrillators Market Forecast 2019 - 2029 6.2 Europe Defibrillators Market Forecast 2019 - 2029 6.2.1 UK Defibrillators Market Forecast 2019 - 2029 6.2.2 France Defibrillators Market Forecast 2019 - 2029 6.2.3 Germany Defibrillators Market Forecast 2019 - 2029 6.2.4 Italy Defibrillators Market Forecast 2019 - 2029 6.2.5 Spain Defibrillators Market Forecast 2019 - 2029 6.2.6 Rest of Europe Defibrillators Market Forecast 2019 - 2029 6.3 Asia-Pacific Defibrillators Market Forecast 2019 - 2029 6.3.1 China Defibrillators Market Forecast 2019 - 2029 6.3.2 Japan Defibrillators Market Forecast 2019 - 2029 6.3.3 India Defibrillators Market Forecast 2019 - 2029 6.3.4 Rest of APAC Defibrillators Market Forecast 2019 - 2029 6.4 Rest of the World (RoW) Defibrillators Market Forecast 2019 - 2029 6.4.1 Latin America Defibrillators Market Forecast 2019 - 2029 6.4.2 Middle East and Africa Defibrillators Market Forecast 2019 - 2029 7. Leading Companies in the Defibrillators Market 7.1 Medtronic PLC: Company Information 7.1.1 Medtronic PLC: Business Overview 7.1.2 Medtronic PLC: Financial Overview 7.1.3 Medtronic PLC: Product Portfolio 7.1.4 Medtronic PLC: Recent Developments 7.1.5 SWOT Analysis 7.2 Boston Scientific Corporation: Company Information 7.2.1 Boston Scientific Corporation: Business Overview 7.2.2 Boston Scientific Corporation: Financial Overview 7.2.3 Boston Scientific Corporation: Product Portfolio 7.2.4 Boston Scientific Corporation: Recent Developments 7.2.5 Boston Scientific Corporation: SWOT Analysis 7.3 Biotronik SE & Co. KG: Company Information 7.3.1 Biotronik SE & Co. KG: Business Overview 7.3.2 Biotronik SE & Co. KG: Product Portfolio 7.3.3 Biotronik SE & Co. KG: Recent Developments 7.4 Abbott Laboratories: Company Information 7.4.1 Abbott Laboratories: Business Overview 7.4.2 Abbott Laboratories: Financial Overview 7.4.3 Abbott Laboratories: Product Portfolio 7.4.4 Abbott Laboratories: Recent Developments 7.4.5 Abbott Laboratories: SWOT Analysis 7.5 LivaNova PLC: Company Information 7.5.1 LivaNova PLC: Business Overview 7.5.2 LivaNova PLC: Financial Overview 7.5.3 LivaNova PLC: Product Portfolio 7.5.4 LivaNova PLC: Recent Developments 7.6 Zoll Medical Corporation: Company Information 7.6.1 Zoll Medical Corporation: Business Overview 7.6.2 Zoll Medical Corporation: Financial Overview 7.6.3 Zoll Medical Corporation: Product Portfolio 7.6.4 Zoll Medical Corporation: Recent Developments 7.6.5 Zoll Medical Corporation: SWOT Analysis 7.7 Physio Control, Inc.: Company Information 7.7.1 Physio Control, Inc.: Business Overview 7.7.2 Physio Control, Inc.: Product Portfolio 7.7.3 Physio Control, Inc.: Recent Developments 7.8 Cardiac Science Corporation: Company Information 7.8.1 Cardiac Science Corporation: Business Overview 7.8.2 Cardiac Science Corporation: Product Portfolio 7.8.3 Cardiac Science Corporation: Recent Developments 7.9 Nihon Kohden Corporation: Company Information 7.9.1 Nihon Kohden Corporation: Business Overview 7.9.2 Nihon Kohden Corporation: Financial Overview 7.9.3 Nihon Kohden Corporation: Product Portfolio 7.9.4 Nihon Kohden Corporation: Recent Developments 7.10 Philips Healthcare: Company Information 7.10.1 Philips Healthcare: Business Overview 7.10.2 Philips Healthcare: Financial Overview 7.10.3 Philips Healthcare: Product Portfolio 7.10.4 Philips Healthcare: Recent Developments 7.10.5 Philips Healthcare: SWOT Analysis 8. Defibrillators Market Dynamics: SWOT and PEST Analysis 8.1 SWOT Analysis 8.1.1 Global Defibrillator Market Drivers 8.1.1.1 Availability of Technologically Advanced Defibrillators 8.1.1.2 Rapidly Growing Aging Population Leading to High Risk of Cardiovascular Diseases 8.1.1.3 Growing Incidence of Cardiovascular Diseases 8.1.1.4 Increasing Awareness and Training programmes Related to Defibrillators 8.1.2 Global Defibrillator Market Restraints 8.1.2.1 Concerns Associated with the Use of Defibrillators 8.1.2.2 Increasing Pricing Pressure on Manufacturers 8.1.2.3 Product Recalls 8.1.3 Global Defibrillator Market Opportunity 8.1.3.1 Focus on Emerging Markets 8.1.4 Global Defibrillator Market Trend 8.1.4.1 Mergers and Acquisitions 8.1.4.2 Development of ICDs and CRT-Ds with full-body MRI scans 8.2 PEST Analysis 8.2.1 Political 8.2.2 Economic 8.2.3 Social 8.2.4 Technological 9. Conclusions and Recommendations 9.1 The Global Defibrillator Market in 2017 and 2029 9.1.1 Current Leading Defibrillators Segments 9.1.2 Leading Defibrillators Companies 9.1.3 Leading Regional Markets 9.2 Global Defibrillators Market Forecast 2017-2029 9.3 The Future of the Defibrillators Market? Appendices Associated Visiongain Reports Visiongain Report Sales Order Form About Visiongain Visiongain Report Evaluation Form List of Tables Table 3.1 Global Defibrillator Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 3.2 Global Defibrillator Market Forecast by Product: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 3.3 Defibrillator Market Forecast by Region: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 3.4 Global Defibrillators Market Dynamics 2018 Table 4.1 Global Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.2 Global Implantable Cardioverter Defibrillators (ICDs) Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.3 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.4 Global Single- Chamber Implantable Cardioverter Defibrillator Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.5 Global Dual- Chamber Implantable Cardioverter Defibrillator Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.6 Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Forecast 2017-2029($bn, AGR %, CAGR %) Table 4.7 Global Subcutaneous Implantable Cardioverter Defibrillators (S-ICD) Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.8 Global External Defibrillator Market Forecast 2017-2029 by Product ($bn, AGR %, CAGR %) Table 4.9 Global Manual External Defibrillators Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.10 Global Automated External Defibrillators (AEDs) Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 4.11 Global Wearable Cardioverter External Defibrillators (WCDs) Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 5.1 Global Defibrillator Market by End-User 2017-2029 ($bn, AGR %, CAGR %) Table 5.2 Global Hospitals and Cardiac Centers Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 5.3 Global Pre-Hospitals Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 5.4 Global Public Access Sector Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 5.5 Global Home Care Defibrillator Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 5.6 Global Other End User Market Forecast 2017-2029 ($bn, AGR %, CAGR %) Table 6.1 Defibrillator Market Forecast Segmented by Regional Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.2 North American Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.3 U.S. Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.4 Canada Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.5 European Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.6 U.K. Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.7 France Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.8 Germany Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.9 Italy Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.10 Spain Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.11 Rest of Europe Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.12 Asia-Pacific Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.13 China Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.14 Japan Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.15 India Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.16 Rest of APAC Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.17 Rest of the World Defibrillators Market Forecast Segmented by National Market: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.18 Latin America Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 6.19 Middle East & Africa Defibrillators Market Forecast: Revenue ($bn), AGR (%) and CAGR (%), 2017-2029 Table 7.1 Medtronic PLC: Company Information Table 7.2 Medtronic PLC: Product Portfolio Table 7.3 Medtronic PLC: Recent Developments Table 7.4 Medtronic PLC: Expansion Table 7.5 Boston Scientific Corporation: Company Information Table 7.6 Boston Scientific Corporation: Product Portfolio Table 7.7 Boston Scientific Corporation: Recent Developments Table 7.8 Biotronik SE & CO. KG: Company Information Table 7.9 Biotronik SE & CO. KG: Product Portfolio Table 7.10 Biotronik SE & CO. KG: Recent Developments Table 7.11 Abbott Laboratories: Company Information Table 7.12 Abbott Laboratories: Product Category Table 7.13 Abbott Laboratories: Recent Developments Table 7.14 LivaNova PLC: Company Information Table 7.15 LivaNova PLC: Product Portfolio Table 7.16 LivaNova PLC: Recent Developments Table 7.17 Zoll Medical Corporation: Company Information Table 7.18 Zoll Medical Corporatio: Product Category Table 7.19 Zoll Medical Corporatio: Recent Developments Table 7.20 Physio Control, Inc.: Company Information Table 7.21 Physio Control, Inc.: Product Portfolio Table 7.22 Physio Control, Inc.: Recent Developments Table 7.23 Cardiac Science Corporation: Company Information Table 7.24 Cardiac Science Corporation: Product Portfolio Table 7.25 Cardiac Science Corporation: Recent Developments Table 7.26 Nihon Kohden Corporation: Company Information Table 7.27 Nihon Kohden Corporation: Product Portfolio Table 7.28 Nihon Kohden Corporation: Recent Developments Table 7.29 Philips Healthcare: Company Information Table 7.30 Philips Healthcare: Product Portfolio Table 7.31 Philips Healthcare: Recent Developments Table 8.1 List of Product Recalls Table 8.2 List of Mergers and Acquisitions in the Defibrillators Market Table 8.3 MRI-Conditional ICDs and CRT-Ds Approved in 2016 List of Figures Figure 1.1 Global Defibrillators Market Segmentation Overview Figure 2.1 Snapshot: Evolution of Defibrillators Figure 3.1 Global Defibrillator Market Forecast: Revenue ($bn), AGR (%), 2017-2029 Figure 3.2 Global Defibrillator Market by Product: 2017-2029 ($bn) Figure 3.3 Defibrillator Market by Region: 2017-2029($bn, AGR %) Figure 4.1 Global Defibrillator Market: 2017-2029 ($bn) Figure 4.2 Global Defibrillator Market by Product: Market Share (%), 2018 Figure 4.3 Global Defibrillator Market by Product: Market Share (%), 2023 Figure 4.4 Global Defibrillator Market by Product: Market Share (%), 2029 Figure 4.5 Global Implantable Cardioverter Defibrillators Market: 2017-2029 ($bn, AGR %) Figure 4.6 Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2018 Figure 4.7 Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2023 Figure 4.8 Global Implantable Cardioverter Defibrillators (ICDs) Market by Sub Segment: Market Share (%), 2029 Figure 4.9 Global Transvenous Implantable Cardioverter Defibrillators Market: 2017-2029 ($bn, AGR %) Figure 4.10 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by Sub Segment: Market Share (%), 2018 Figure 4.11 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by Sub Segment: Market Share (%), 2023 Figure 4.12 Global Transvenous Implantable Cardioverter Defibrillator (T-ICD) Market by Sub Segment: Market Share (%), 2029 Figure 4.13 Global Single-Chamber Implantable Cardioverter Defibrillator Market Forecast: 2017-2029 ($bn, AGR %) Figure 4.14 Global Dual-Chamber Implantable Cardioverter Defibrillator Market Forecast: 2017-2029 ($bn, AGR %) Figure 4.15 Global Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Market Forecast: 2017-2029 ($bn, AGR %) Figure 4.16 Global Subcutaneous Implantable Cardioverter Defibrillators (CRT-Ds) Market Forecast: 2017-2029 ($bn, AGR %) Figure 4.17 Global External Defibrillators Market Forecast 2017-2029 ($bn, AGR %) Figure 4.18 Global External Defibrillators Market by Sub Segment: Market Share (%), 2018 Figure 4.19 Global External Defibrillators Market by Sub Segment: Market Share (%), 2023 Figure 4.20 Global External Defibrillators Market by Sub Segment: Market Share (%), 2029 Figure 4.21 Global Manual External Defibrillators Forecast 2017-2029 ($bn, AGR %) Figure 4.22 Global Automated External Defibrillators Market by Sub Segment: Market Share (%), 2018 Figure 4.23 Global Automated External Defibrillators Market by Sub Segment: Market Share (%), 2023 Figure 4.24 Global Automated External Defibrillators Market by Sub Segment: Market Share (%), 2029 Figure 4.25 Global Wearable Cardioverter External Defibrillators Forecast 2017-2029 ($bn, AGR %) Figure 5.1 Global Defibrillators Market by End-User: 2017-2029 ($bn) Figure 5.2 Global Defibrillators Market by End User: Market Share (%), 2018 Figure 5.3 Global Defibrillators Market by End User: Market Share (%), 2023 Figure 5.4 Global Defibrillators Market by End User: Market Share (%), 2029 Figure 5.5 Global Hospitals and Cardiac Centers Defibrillators Market Forecast 2017- 2029 ($bn, AGR %) Figure 5.6 Global Pre-Hospitals Defibrillators Market Forecast 2017-2029 ($bn, AGR %) Figure 5.7 Global Public Access Sector Defibrillators Market Forecast 2017-2029 ($bn, AGR %) Figure 5.8 Global Home Care Defibrillator Market Forecast 2017-2029 ($bn, AGR %) Figure 5.9 Global Other End User Market Forecast 2017-2029 ($bn, AGR %) Figure 6.1 Defibrillators Market Forecast Segmented by Regional Market: 2017-2029 ($bn) Figure 6.2 Global Defibrillator Market by Region: Market Share (%), 2018 Figure 6.3 Global Defibrillator Market by Region: Market Share (%), 2023 Figure 6.4 Global Defibrillator Market by Region: Market Share (%), 2029 Figure 6.5 North American Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.6 North American Defibrillators Market Forecast Segmented by National Market: 2017-2029 ($bn) Figure 6.7 North American Defibrillator Market by Country: Market Share (%), 2018 Figure 6.8 North American Defibrillator Market by Country: Market Share (%), 2023 Figure 6.9 North American Defibrillator Market by Country: Market Share (%), 2029 Figure 6.10 U.S. Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.11 Canada Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.12 European Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.13 European Defibrillators Market Forecast Segmented by National Market: 2017-2029 ($bn) Figure 6.14 European Defibrillators Market by Country: Market Share (%), 2018 Figure 6.15 European Defibrillators Market by Country: Market Share (%), 2023 Figure 6.16 European Defibrillators Market by Country: Market Share (%), 2029 Figure 6.17 U.K. Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.18 France Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.19 Germany Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.20 Italy Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.21 Spain Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.22 Rest of Europe Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.23 Asia-Pacific Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.24 Asia-Pacific Defibrillators Market Forecast Segmented by National Market: 2017-2029 ($bn) Figure 6.25 APAC Defibrillators Market by Country: Market Share (%), 2018 Figure 6.26 APAC Defibrillators Market by Country: Market Share (%), 2023 Figure 6.27 APAC Defibrillators Market by Country: Market Share (%), 2029 Figure 6.28 China Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.29 Japan Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.30 India Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.31 Rest of APAC Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.32 Rest of the World Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.33 Rest of the World Defibrillators Market Forecast: 2017-2029 ($bn) Figure 6.34 RoW Defibrillator Market by Region: Market Share (%), 2018 Figure 6.35 RoW Defibrillator Market by Region: Market Share (%), 2023 Figure 6.36 RoW Defibrillator Market by Region: Market Share (%), 2029 Figure 6.37 Latin American Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 6.38 Middle East & Africa Defibrillators Market Forecast: 2017-2029 ($bn, AGR %) Figure 7.1 Medtronic PLC: Financial Overview 2014-2018 Figure 7.2 Medtronic PLC: Segment Overview - 2018 Figure 7.3 Medtronic PLC: Geographical Overview - 2018 Figure 7.4 Medtronic PLC: SWOT Analysis Figure 7.5 Boston Scientific Corporation: Financial Overview 2013-2017 Figure 7.6 Boston Scientific Corporation: Segment Overview - 2018 Figure 7.7 Boston Scientific Corporation: Geographic Overview - 2018 Figure 7.8 Boston Scientific Corporation: SWOT Analysis Figure 7.9 Abbott Laboratories: Financial Overview 2013-2017 Figure 7.10 Abbott Laboratories: Segment Overview - 2018 Figure 7.10 Abbott Laboratories: Geographic Overview - 2018 Figure 7.12 Abbott Laboratories: SWOT Analysis Figure 7.13 LivaNova PLC: Financial Overview 2013-2017 Figure 7.14 LivaNova PLC: Segment Overview - 2018 Figure 7.15 LivaNova PLC: Geographic Overview - 2018 Figure 7.16 Zoll Medical Corporation: Financial Overview Figure 7.17 Zoll Medical Corporation: SWOT Analysis Figure 7.18 Nihon Kohden Corporation: Financial Overview 2013-2017 Figure 7.19 Nihon Kohden Corporation: Segment Overview - 2018 Figure 7.20 Nihon Kohden Corporation Geographic Overview - 2018 Figure 7.21 Philips Healthcare: Financial Overview 2013 - 2017 Figure 7.22 Nihon Kohden Corporation: Segment Overview - 2018 Figure 7.23 Nihon Kohden Corporation Geographic Overview - 2018 Figure 7.24 Philips Healthcare: SWOT Analysis Figure 8.1 Number of Cardiovascular Deaths (Million) by Region (2015 to 2030) Figure 9.1 Global Defibrillator Market: 2017-2029 ($bn, AGR %) Figure 9.2 Global Defibrillator Market by Product: 2017-2029 ($bn) Figure 9.3 Defibrillator Market by Region: 2017-2029 ($bn)
Abbott Laboratories ADS, Inc. Air Force Alere Inc. American Heart Association (AHA) Apama Medical Inc. Asahi Kasei Group Company Aska Equipments Ltd. Augmenix, Inc. Aurora Capital Group Aurora Resurgence Aziyo Badger State Sheriffs' Association (BSSA) Barcelona City Council Bavarian Red Cross BIOTRONIK BIOTRONIK SE & Co. KG Boston Scientific Corporation British Red Cross Caisson Interventional, LLC. Cardiac Science Corporation China Food and Drug Administration Crospon Cyberonics Inc. Department of Education, UK European Heart Rhythm Association Farong Shen in Zhejiang Lucheng Hospital Groveland Fire Department Health Canada Heart Rhythm Society (HRS) HEART UK HeartSine Technologies ImThera Medical Japanese Ministry of Health, Labour and Welfare Johns Hopkins University Koninklijke Philips N.V. Lek Life-Assist, Inc. Lippert Components, Inc. LivaNova Plc Mazor Robotics Medtronic Emergency Response Systems, Inc. Medtronic plc Metrax GmbH Metrax GmbH MicroPort Scientific MicroPort Scientific Corporation MicroPort Sorin CRM (Shanghai) Co. Ltd Mountain Rescue Association of Slovenia (MRAS) National Health Service National Taxi Association Nihon Kohden Nihon Kohden Corporation Nutrino nVision Medical Corporation Philips Healthcare Physio-Control, Inc. Progetti Srl Promega Srl. Quinton Cardiology Systems, Inc. Sand Holdco Limited Sand Holdco PLC Saudi Heart Rhythm Society Securus Medical Group, Inc. Singapore Civil Defence Force (SCDF) Singapore Heart Foundation Smith & Nephew Sorin S.p.A Spacelabs Healthcare St. Jude Medical, Inc. Stentor, Inc. Stryker Corporation Symetis SA TandemLife The Spectranetics Corporation United Nations United States Food and Drugs Administration US Army VisionSense Walmart Canada Wei Hua in Beijing Fuwai Hospital World Health Organization World Heart Federation (WHF) ZOLL Medical Corporation